Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains

The Journal of Clinical Investigation
S LukomskiJ M Musser

Abstract

Cysteine proteases have been implicated as important virulence factors in a wide range of prokaryotic and eukaryotic pathogens, but little direct evidence has been presented to support this notion. Virtually all strains of the human bacterial pathogen Streptococcus pyogenes express a highly conserved extracellular cysteine protease known as streptococcal pyrogenic exotoxin B (SpeB). Two sets of isogenic strains deficient in SpeB cysteine protease activity were constructed by integrational mutagenesis using nonreplicating recombinant plasmids containing a truncated segment of the speB gene. Immunoblot analyses and enzyme assays confirmed that the mutant derivatives were deficient in expression of enzymatically active SpeB cysteine protease. To test the hypothesis that the cysteine protease participates in host mortality, we assessed the ability of serotype M3 and M49 wild-type strains and isogenic protease-negative mutants to cause death in outbred mice after intraperitoneal inoculation. Compared to wild-type parental organisms, the serotype M3 speB mutant lost virtually all ability to cause mouse death (P < 0.00001), and similarly, the virulence of the M49 mutant was detrimentally altered (P < 0.005). The data unambiguously dem...Continue Reading

References

Aug 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B SchwartzR R Facklam
Jul 1, 1992·The Journal of Infectious Diseases·S E HolmM Norgren
Oct 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·M R WesselsT J DiCesare
Apr 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·J M MusserR K Selander
Nov 15, 1984·Analytical Biochemistry·S S Twining
Aug 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·V KapurJ M Musser
Jan 1, 1993·Annual Review of Microbiology·J H McKerrowJ Bouvier
Nov 1, 1995·Trends in Microbiology·J PotempaJ Travis
Feb 1, 1996·The Journal of Clinical Investigation·M DewerchinD Collen
Jul 1, 1996·The Journal of Experimental Medicine·R H Schwartz
Mar 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J R DiPersioK Dinsa
Jan 1, 1997·JAMA : the Journal of the American Medical Association·F R CockerillM T Osterholm

❮ Previous
Next ❯

Citations

Mar 24, 2007·Journal of Biomedical Science·Chia-Wen ChangMing-T Lin
Nov 30, 2000·Current Infectious Disease Reports·G J Baracco, A L Bisno
Mar 10, 2001·Veterinary Microbiology·B A MungallC C Pollitt
Apr 8, 2006·Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine·E Everest
Feb 27, 1999·Current Opinion in Microbiology·G Molinari, G S Chhatwal
Oct 9, 2002·Molecular Microbiology·Carlos Hidalgo-GrassEmanuel Hanski
Feb 10, 2010·Proceedings of the National Academy of Sciences of the United States of America·Stephen B BeresJames M Musser
Jan 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Randall J OlsenJames M Musser
Feb 25, 2009·The Journal of Biological Chemistry·Chih-Chieh WangWoei-Jer Chuang
Apr 3, 2002·The EMBO Journal·Ulrich von Pawel-RammingenLars Björck
Oct 12, 2012·The Journal of Antimicrobial Chemotherapy·Ernest A AzzopardiDavid W Thomas
Jul 25, 2000·Clinical Microbiology Reviews·M W Cunningham
Jun 23, 2006·Infection and Immunity·Brian HendersonAnthony R M Coates
Feb 26, 2000·Infection and Immunity·G L DarmstadtC E Rubens
Oct 13, 2001·Infection and Immunity·M Collin, A Olsén
Feb 13, 2001·Infection and Immunity·M S ChausseeJ M Musser
Nov 20, 2002·Infection and Immunity·Mattias CollinArne Olsén
Jun 18, 2002·Infection and Immunity·Melody N NeelyMichael Caparon
Aug 17, 2002·Infection and Immunity·W T M JansenR Schnabel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.